(Q50241761)

English

Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies.

scientific article published on 20 August 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 February 2018

http://europepmc.org/abstract/MED/27544498

Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies. (English)

1 reference

Europe PubMed Central

28 February 2018

http://europepmc.org/abstract/MED/27544498

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Brit Mollenhauer

7

object named as

Brit Mollenhauer

1 reference

Europe PubMed Central

28 February 2018

8

object named as

Inga Zerr

1 reference

Europe PubMed Central

28 February 2018

http://europepmc.org/abstract/MED/27544498

author name string

Franc Llorens

1

1 reference

Europe PubMed Central

28 February 2018

http://europepmc.org/abstract/MED/27544498

Matthias Schmitz

2

1 reference

Europe PubMed Central

28 February 2018

http://europepmc.org/abstract/MED/27544498

Daniela Varges

3

1 reference

Europe PubMed Central

28 February 2018

http://europepmc.org/abstract/MED/27544498

Niels Kruse

4

1 reference

Europe PubMed Central

28 February 2018

http://europepmc.org/abstract/MED/27544498

Nadine Gotzmann

5

1 reference

Europe PubMed Central

28 February 2018

http://europepmc.org/abstract/MED/27544498

Karin Gmitterová

6

1 reference

Europe PubMed Central

28 February 2018

http://europepmc.org/abstract/MED/27544498

publication date

20 August 2016

1 reference

Europe PubMed Central

28 February 2018

http://europepmc.org/abstract/MED/27544498

Journal of Neurology

1 reference

Europe PubMed Central

28 February 2018

http://europepmc.org/abstract/MED/27544498

263

1 reference

Europe PubMed Central

28 February 2018

http://europepmc.org/abstract/MED/27544498

2271-2277

1 reference

Europe PubMed Central

28 February 2018

http://europepmc.org/abstract/MED/27544498

11

1 reference

Europe PubMed Central

28 February 2018

http://europepmc.org/abstract/MED/27544498

https://scigraph.springernature.com/pub.10.1007/s00415-016-8259-0

0 references

News and controversies regarding essential tremor

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Intellectual impairment in Parkinson's disease: clinical, pathologic, and biochemical correlates

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

α-Synuclein in Parkinson disease and other neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Clinical diagnostic criteria for dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Neurochemistry and the non-motor aspects of PD.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Synucleinopathies: clinical and pathological implications

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Second consensus statement on the diagnosis of multiple system atrophy

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

CSF biomarkers and clinical progression of Parkinson disease

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

The neurobiological basis of cognitive impairment in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

The diagnostic utility of cerebrospinal fluid alpha-synuclein analysis in dementia with Lewy bodies - a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Increased albumin CSF/serum ratio in dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Essential tremor associated with focal nonnigral Lewy bodies: a clinicopathologic study.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Biomarkers in biological fluids for dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Tau and p-tau as CSF biomarkers in dementia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Lewy body dementias.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Use of CSF α-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

A systematic review of prevalence and incidence studies of dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8259-0

21 January 2018

Is there a relationship between Parkinson's disease and essential tremor?

1 reference

https://pubmed.ncbi.nlm.nih.gov/27544498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship between Parkinson's disease and essential tremor: review of clinical, epidemiologic, genetic, neuroimaging and neuropathological data, and data on the presence of cardinal signs of parkinsonism in essential tremor

1 reference

https://pubmed.ncbi.nlm.nih.gov/27544498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27544498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: evidence from a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27544498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Index for rating diagnostic tests

1 reference

https://pubmed.ncbi.nlm.nih.gov/27544498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Using cerebrospinal fluid marker profiles in clinical diagnosis of dementia with Lewy bodies, Parkinson's disease, and Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27544498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased α-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27544498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Diagnostic and Differential Diagnosis Utility of Cerebrospinal Fluid α -Synuclein Levels in Parkinson's Disease: A Meta-Analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27544498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27544498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00415-016-8259-0

1 reference

Europe PubMed Central

28 February 2018

http://europepmc.org/abstract/MED/27544498

1 reference

Europe PubMed Central

28 February 2018

http://europepmc.org/abstract/MED/27544498

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50241761&oldid=1497453325"